SALT LAKE CITY, UT--(Marketwire - March 06, 2008) - Myriad Genetics, Inc. (NASDAQ: MYGN), announced today that Peter Meldrum, President and CEO, is scheduled to present an overview of the Company at the 11th Annual Lehman Brothers Global Healthcare Conference, at 9:30 a.m. on March 19, at the Loews Miami Beach Hotel in South Beach, Florida.
